Abbott raises annual earnings outlook as COVID-19 test sales rebound
Go back to Abbott raises annual earnings outlook as COVID-19 test sales rebound| Abbott Laboratories (NYSE: ABT) | Delayed: 88.41 -0.09 (0.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.50 | 52 Week High | $46.38 | |||
| Open | $88.64 | 52 Week Low | $36.00 | |||
| Day High | $89.44 | P/E | 58.94 | |||
| Day Low | $87.76 | EPS | $1.50 | |||
| Volume | 41,964,845 | |||||
